Skip to content

Fecal Microbiota Transplantation for Pancreatitis With Infectious Complications(FMTPIC)

Fecal Microbiota Transplantation in SAP(Severe Acute Pancreatitis)Patients With Infectious Complications

Status
UNKNOWN
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02318147
Enrollment
60
Registered
2014-12-17
Start date
2016-11-30
Completion date
2018-12-31
Last updated
2017-10-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Pancreatitis, Bacterial Translocation, Fecal Microbiota Transplantation, Infectious Complications

Keywords

Severe acute pancreatitis, Fecal Microbiota Transplantation, Bacterial Translocation, Infectious Complications

Brief summary

Infectious complications are responsible for most of deaths in acute pancreatitis.Intestinal barrier dysfunction and increased intestinal permeability was associated with bacterial translocation which is believed to prompted these infections.The purpose of this clinical trail is to observe the potential capability of FMT in reduce the bacterial translocation and alleviate infectious complications by the reconstruction of a gut functional state.

Detailed description

Investigators aims to restore the intestinal bacteria homeostasis through FMT by retention enema with fresh bacteria,thus minimizing bacterial translocation and alleviating infectious complications. The investigators will further examine the effect of FMT on the incidence of infectious complications,duration of clinical course and mortality.

Interventions

PROCEDUREFecal Microbiota Transplantation

FMT by retention enema with fresh bacteria from healthy donor

DRUGThe traditional treatment

the traditional treatments according to associated guidelines

Sponsors

The First Affiliated Hospital of Nanchang University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

1. Diagnosis of severe acute pancreatitis from the First Affiliated Hospital of Nanchang University according to the Classification of acute pancreatitis-2012: revision of the Atlanta classification and definitions by international consensus 2. Onset of pancreatitis more than 2 weeks 3. Intestinal bacterium screening tips gut dysbacteriosis 4. Patients with symptoms of infection, such as fever, abdominal pain or blood culture and pancreatic necrosis drainage culture positive patients.

Exclusion criteria

1. SAP complicated by Gastrointestinal bleeding or Intestinal fistula 2. Pregnancy and lactation women 3. Not signed the informed consent

Design outcomes

Primary

MeasureTime frameDescription
The control of infectious complicationsFrom admission to dischargeThe temperature recovered to normal for 3 days. The inflammatory cytokines decreased to the normal value.

Secondary

MeasureTime frameDescription
C-reactive protein(CRP)level1day before intervention,7days and 14days after interventionC-reactive protein (CRP) is a inflammatory prognostic marker
Procalcitionin(PCT)level1day before intervention,7days and 14days after interventionProcalcitionin(PCT)level is a inflammatory prognostic marker
Length of Intensive care time and hospital stayFrom admission to dischargeThe time of stay in the intensive care unit and hospital
MortalityFrom admission to dischargeThe incidence of death during the time frame

Countries

China

Contacts

Primary ContactYin Zhu, MD
zhuyin27@sina.com13970841464
Backup ContactLingyu Luo, MD
15270855639@163.com15270855639

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026